pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
About pharmaphorum
3 days ago · pharmaphorum.com is a leading online destination for healthcare and pharmaceutical industry news, insight, and debate – as is its associated digital magazine Deep …
News | Timely industry updates for pharma and biotech leaders
3 days ago · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
Deep Dive: Patients & Partnerships 2024 | pharmaphorum
Nov 8, 2024 · Delve into the critical issues surrounding patients, partnerships, and the US election in 2024. Explore the impact on drug development, pricing, and patient access in this in-depth …
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, …
Transforming pharmacovigilance: The revolutionary impact of …
2 days ago · In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in pharmacovigilance, the science dedicated to ensuring drug safety.
Patients’ changing opinions of pharma - pharmaphorum
Respondents listed the industry’s achievements in R&D as the area where the most progress has been made in the last five years. It was the landslide winner, cited by 29% of those …
Coming soon: The Life Sciences Industry Report 2025 – insights …
Nov 13, 2024 · Discover the latest trends and predictions in the life sciences industry with a focus on GLP-1 and AI technologies in our industry report for 2025. Don't miss out on valuable insights.
Deep-Dive | pharmaphorum
5 days ago · Dear Readers, The 2024 US election has cast a long shadow over the pharma industry, with the policies of the next administration poised to reshape drug development, …
Pills and polls: What the 2024 election means for pharma
President Biden’s passage of the Inflation Reduction Act, which, among many other provisions, allowed Medicare to negotiate drug prices for the first time and set a $35-per-month out-of …